Findings from GAP70+, the first study to "systematically describe baseline symptom burden as measured by the Patient-Reported Outcomes Common Terminology Criteria for Adverse Events (PRO-CTCAE) in older adults with advanced cancer" was recently published in the Journal of Clinical Oncology.
According to the GAO70+ study, more than 25% of new cancer diagnoses occur in older patients, however this demographic is often now well-represented in clinical trials, which limits understanding of the various treatment options available.
To read more about this study, click here.
Source mentioned: Culakova E, Mohile SG, Peppone L, et al. Effects of a Geriatric Assessment Intervention on Patient-Reported Symptomatic Toxicity in Older Adults With Advanced Cancer. JCO; Published online 10 November. DOI: 10.1200/JCO.22.00738
No comments:
Post a Comment